Background Interatrial block (IAB) on electrocardiography (ECG) and reduced P wave voltage reflect atrial abnormalities which may contribute to development of atrial fibrillation (AF). Purpose We aimed to assess the value of a recently proposed ECG risk score that combines the morphology, voltage and length of the P wave (MVP score) for prediction of incident AF in a prospective population-based setting. Material and methods The study population is based on the large, prospective Malmö Preventative Project (MPP) cohort. We included subjects without a history of AF, with a readable ECG in sinus rhythm and an echocardiography performed in 2002–2006 (n=983, mean age 70±5 years, 38% females). Median follow-up was 4.2 (IQR 3.7–4.8) years. ECGs were digitally processed using the Glasgow algorithm. Advanced IAB (aIAB) was defined as a P-wave ≥120 ms and biphasic morphology (+/−) in inferior leads, partial IAB (pIAB) as P-wave ≥120 ms and a monophasic positive morphoology in inferior leads. MVP score was calculated based on the P-wave morphology in inferior leads, voltage in lead 1, and P-wave duration (Table 1).Incident AF events (n=66, 7%) were obtained from the Swedish Hospital Discharge Register and Cause of Death Register. Cox regression analysis and Kaplan Meier curve analysis were used to study the association of echocardiographic and P-wave characteristics with the risk of new onset AF. Results At baseline the mean MVP score was 1±1, none of the subjects had MVP score above 4. MVP score correlated with left atrial (LA) area: Pearson r=0.192, p<0.001. After adjustment for age, gender and LA enlargement expressed as LA area >20 cm2, new onset AF was associated with MVP score 4 (HR 6.17, 95% CI 1.76–21.64 compared to those with MVP score <4, Figure 1). Neither aIAB (univariate HR 1.93 CI 95% 0.82–4.56), nor pIAB (univariate HR 1.16 CI 95% 0.52–2.55) predicted incident AF. Conclusion In a population-based elderly epidemiological cohort, the ECG-based MVP score was significantly associated with incident AF, independently of LA enlargement. Funding Acknowledgement Type of funding sources: Private grant(s) and/or Sponsorship. Main funding source(s): The Swedish Heart-Lung Foundation
Introduction Tension band wiring of olecranon fractures has high reported rates of complications and reoperations. We aimed to compare classic tension band wiring to cerclage fixation without K-wires in the treatment of displaced olecranon fractures in elderly patients. The primary outcome was reoperation. Secondary outcomes included complications and patient reported outcomes. Outcomes following non-operative treatment were also studied. Materials and methods Patients aged > 69 years presenting with Mayo class 2a and 2b olecranon fractures at our institution from 2004 through 2016 (n = 239) were eligible for study. Fracture type, treatment method, complications and reoperations were assessed from radiographs and hospital files. QuickDASH surveys were collected by mail. Results Patients operated with tension band wire technique had more reoperations (p value 0.03): relative risk (RR) 2.2 (CI 1.08–4.3), odds ratio (OR) 2.6 (CI 1.05–6.4), and complications (p value 0.001): RR 2.5 (CI 1.51–4.1), OR 3.7 (CI 1.67–8.2), compared with those operated with cerclage technique. Non-operative treatment yielded similar complication (p value 0.2) and reoperation rates (p value 0.06) as cerclage fixation. The answer rate was insufficient to compare QuickDASH scores between treatments methods. Conclusions In patients 70 years and older undergoing cerclage fixation for displaced stable olecranon fractures (Mayo class 2), the reoperation and complications rates were less than half of those in patients undergoing TBW fixation. Non-operative treatment yielded similar reoperation and complication rates to cerclage fixation, in selected cases. Level of evidence III—retrospective comparative cohort study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.